Lexeo Therapeutics Inc. C... (LXEO)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

6.88

-0.51%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20
Revenue	-	654.00K	1.66M	518.48K
Cost of Revenue	1.84M	1.15M	13.40K	-
Gross Profit	-1.84M	-491.00K	1.64M	518.48K
Operating Income	-68.51M	-60.51M	-50.64M	-4.59M
Interest Income	2.87M	1.32M	15.00K	-
Pretax Income	-66.39M	-59.28M	-50.62M	-5.15M
Net Income	-66.39M	-59.28M	-50.62M	-5.15M
Selling & General & Admin	13.54M	12.00M	7.17M	787.50K
Research & Development	53.13M	49.16M	45.12M	4.32M
Other Expenses	-	-2.00K	-155	4.24K
Operating Expenses	68.51M	61.16M	52.29M	5.11M
Interest Expense	205.00K	91.00K	-	147.15K
Selling & Marketing Expenses	-1.84M	-	-	-
Cost & Expenses	68.51M	61.16M	52.29M	5.11M
Income Tax	-	89.00K	-155	147.15K
Shares Outstanding (Basic)	26.65M	24.67M	24.67M	24.67M
Shares Outstanding (Diluted)	26.65M	24.67M	24.67M	24.67M
EPS (Basic)	-2.49	-2.4	-2.05	-0.21
EPS (Diluted)	-2.49	-2.4	-2.05	-0.21
EBITDA	-66.67M	-58.04M	-50.62M	-4.58M
Depreciation & Amortization	1.84M	1.15M	13.40K	4.24K